Schedule 13G ownership disclosure

Syndax Pharmaceuticals Inc

Security class unavailable · CUSIP: 87164F105

Event date: 2020-11-03

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-20-006675
Form type
SC 13G
Filer
Avidity Partners Management LP
CIK
CIK 1791827
Filed
Nov 04, 2020
Reporting period
Nov 03, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub